Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: CusterInvestor who wrote (124195)	11/28/2004 1:05:08 AM
From: Henry Niman	Respond to of 208838

Flu mist has the same three virus as in the killed vaccine. This year's human flu shot is better than most years because it has Fujian (for the first time) and so far this year all H3N2 subtypes have been Fujian, so this year's shot will help with human flu. The other influenza A is H1N1, so antibodies against the N1 could help against H5N1 (they both have N1, although they are not all that close). If the pandemic strain picks up part of H1 or H3, then the human flu shot could help on the H side also. I would say that a human shot is better than none. At this time no one has a pandemic flu shot.